Trials / Conditions / Pneumococcal Conjugate Vaccine

Pneumococcal Conjugate Vaccine

8 registered clinical trials studyying Pneumococcal Conjugate Vaccine — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Completed	A Study Assessing 13-valent Pneumococcal Conjugate Vaccine in Healthy Chinese Infants and Young Children NCT03574389	Pfizer	Phase 3
Unknown	Paediatric Post Pneumococcal Conjugate Vaccine Nasopharyngeal Carriage Study NCT04401488	University Hospital Southampton NHS Foundation Trust	—
Completed	A Phase 3 Trial Evaluating the Safety, Tolerability, and Immunogenicity of a 13-valent Pneumococcal Conjugate NCT01646398	Pfizer	Phase 3
Recruiting	Invasive Pneumococcal Disease Study NCT04664556	Association Clinique Thérapeutique Infantile du val de Marne	—
Completed	Study Evaluating Prevnar Infant Long-term Immune Response Versus Prevnar Naive Cohort NCT00824850	Pfizer	Phase 2
Completed	Study Evaluating 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Children With Sickle Cell Disease NCT00918580	Pfizer	Phase 3
Completed	Study Evaluating A 13-Valent Pneumococcal Conjugate Vaccine Administered to Infants in Taiwan NCT00688870	Wyeth is now a wholly owned subsidiary of Pfizer	Phase 3
Recruiting	National Bacterial Meningitis Study NCT04664569	Association Clinique Thérapeutique Infantile du val de Marne	—